VS 21-303 Health Management on U.S. Feedlots 2020 Phase II Questio

National Animal Health Monitoring System (NAHMS); Health Management on U.S. Feedlots 2020

VS Form 21-303 Phase 2 Questionnaire

Respondents

OMB: 0579-0079

Document [pdf]
Download: pdf | pdf
According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a
person is not required to respond to a collection of information unless it displays a valid OMB control
number. The valid OMB control number for this information collection is 0579-0079. The time required
to complete this information collection is estimated to average 1 hour per response, including the time
to review instructions, search existing data resources, gather the data needed, and complete and
review the information collected.
UNITED STATES DEPARTMENT OF AGRICULTURE
ANIMAL AND PLANT HEALTH INSPECTION SERVICE
VETERINARY SERVICES
NATIONAL ANIMAL HEALTH MONITORING SYSTEM
2150 CENTRE AVE, BLDG B
FORT COLLINS, CO 80526

OMB Approved
0579-0079
EXP: XX/20XX

Health Management on
U.S. Feedlots 2020
Phase 2 Questionnaire

Beginning time (military) ..............................................................................................
Ending time (military)………………………………………………………………………….
State FIPS:______ Operation #:_________ Interviewer:_______ Date:
2 digits
4 digits
initials

______
_____

/
/
mm/dd/yy

The information you provide will be used for statistical purposes only. In accordance with the Confidential
Information Protection provisions of Title V, Subtitle A, Public Law 107–347 and other applicable Federal
laws, your responses will be kept confidential and will not be disclosed in identifiable form to anyone
other than employees or agents. By law, every employee and agent has taken an oath and is subject to a
jail term, a fine, or both, if he or she willfully discloses ANY identifiable information about you or your
feedlot. Response is voluntary.

General Instructions

Unless otherwise noted, questions refer to the time period from September 1, 2019, to August 31, 2020.
We would like to know about all cattle and calves on feed for the slaughter market, regardless of
ownership, on this particular feedlot.
• Include cattle being fed by you for others.
• Exclude any of your cattle being custom fed in feedlots operated by others.
• Exclude cattle being “backgrounded only” for sale as feeders, for later placement on feed on
another feedlot, or to be returned to pasture.
• Exclude cows and bulls being fed by you for the slaughter market
If “Don’t Know” is provided as an answer option, it is abbreviated as “DK.”
If “Not Applicable” is provided as an answer option, it is abbreviated as “NA.”
The following 4-point scale is utilized in many questions when possible instead of asking specifically for
percentages. This is done because we recognize that in many cases percentages supplied are
approximations and we would like the reponse to reflect that.
“None” (0%)
“Some (50% or less)
“Most” (51% or more)
“All” (100%)
If a different scale is used it is specified in the question.

VS Form 21-303
September 2020

1

NAHMS ID: _____________________

Section A—Cattle Health and Health Practices
Preconditioning and Backgrounding
1. Preconditioning and backgrounding comprises procedures such as acclimatization to feed
bunks, vaccinations, implants, antibiotic use, weaning, deworming, castration, and dehorning that occur
before cattle arrive at the feedlot. For this question, reliable information about preconditioning and
backgrounding is defined as information that is trusted, but not necessarily documented.
For each of the following arrival weight and breed classes, answer yes or no for whether they were
placed on this feedlot. If yes, for what proportion of these cattle did you have reliable information about
pre-conditioning/backgrounding they received prior to arrival at this feedlot?
Reliable information?

Weight class and
breed placed on the
feedlot?

None

Some

Most

All

1 Yes
3 No
1 Yes
3 No
1 Yes
3 No
1 Yes
3 No

If No, SKIP to 2b
If Yes 

1

2

3

4

If No, SKIP to 2c
If Yes 

1

2

3

4

If No, SKIP to 2d
If Yes 

1

2

3

4

If No, SKIP to 2e
If Yes 

1

2

3

4

e. Dairy or dairy cross breed cattle

1 Yes
3 No

If No, SKIP to 2f
If Yes 

1

2

3

4

f. Dairy or dairy cross breed cattle

1 Yes
3 No

If No, SKIP to 3
If Yes 

1

2

3

4

a. Beef breed cattle

(less than 400 lb at arrival)

b. Beef breed cattle

(400-699 lb at arrival)

c. Beef breed cattle

(700 lb or greater at arrival)

d. Dairy or dairy cross breed cattle
(less than 400 lb at arrival)

(less than 400-699 lb at arrival)
(700 lb or greater at arrival)

2.Between September 1, 2019 and August 31, 2020, were all cattle placed on this
feedlot bred and raised by this operation?

1 Yes 3 No
4 DK

[If Question 2 = Yes, then SKIP to Question 6]
3. How important is it to have reliable information on the preconditioning and backgrounding that cattle
received prior to arrival? [Choose one only]
Moderately
Extremely
Not important
Slightly important
Very important
important
important
1
2
3
4
5
[If Question 3 = Not Important, SKIP to Question 6]
4. Are you able to access all the reliable information that you want?

1 Yes 3 No

[If Question 4 = Yes, SKIP to Question 6]
5. Why can’t you access the reliable information that you want?
a.
b.
c.
d.
e.

Finding cattle to purchase for which this information is known is inconvenient.
Cattle are purchased at a sale barn where this information is not available.
Cattle for which this information is known are too expensive.
There is no practical mechanism for transfer of this information.
Other (specify:_____________________________________________)

VS Form 21-303
September 2020

1 Yes 3 No
1 Yes 3 No
1 Yes 3 No
1 Yes 3 No
1 Yes 3 No
2

NAHMS ID: _____________________
6. When you were aware of the history of cattle you purchased, or in calves you raised yourself, what
proportion of the cattle had the following pre-conditioning and backgrounding procedures performed?
None

Some

Most

All

DK

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

d. Given modified live, not killed, respiratory vaccines?

1

2

3

4

5

e. Weaned 4-6 weeks before arrival at feedlot?

1

2

3

4

5

f. Weaned more than 6 weeks before arrival at feedlot?

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

a. Introduction to the feed bunk
b. Given respiratory vaccines less than 2 weeks prior to or at
weaning?
c. Given respiratory vaccines more than 2 weeks prior to weaning?

g. Bull calves and/or bulls castrated at least 3 weeks prior to arrival
at feedlot ?
h. Non-polled cattle dehorned at least 3 weeks prior to arrival at
feedlot? (write N/A in margin if only naturally polled cattle placed)
i. Treated for external or internal parasites?
j. Given antibiotics within 4 weeks of arrival at feedlot?
Initial Processing and Management at the Feedlot

7. Were cattle assessed for their risk for bovine respiratory disease when they arrived at
this feedlot and initial processing protocols modified based on this assessment?

1 Yes 3 No

[If Question 7 = No, SKIP to Question 9]
8. How important were the following factors when making this risk assessment?
Not
Important

Slightly
Important

Moderately
Important

Very
Important

Extremely
Important

1

2

3

4

5

b. Arrival weight class

1

2

3

4

5

c. Appearance of cattle at arrival
d. Respiratory disease in cattle previously
received from same source
e. Presence of respiratory disease in some
cattle in group
f. Whether cattle were commingled with
other cattle prior to arrival
g. Geographic origin of the cattle

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

h. Lack of previous respiratory vaccination
i. Lack of preconditioning/backgrounding

1
1

2
2

3
3

4
4

5
5

j. Season of the year

1

2

3

4

5

k. Weather at time of arrival at the feedlot

1

2

3

4

5

l. Experience of receiving crew
m. Breed of cattle
n. History of prior antibiotic treatment

1
1
1

2
2
2

3
3
3

4
4
4

5
5
5

o. Other (specify:____________________)

1

2

3

4

5

a. Long shipping distance

VS Form 21-303
September 2020

3

NAHMS ID: _____________________
9. Processing includes procedures such as vaccinations, tagging, implants, deworming,
mineral or vitamin supplementation, castration, dehorning, and antibiotic administrations.
Excluding cattle processed separately for treating illness, were any cattle processed as a
group at, or within 4 weeks, of placement?

1 Yes 3 No

[If Question 9 = NO, then SKIP to Question 13]
10. What proportion of cattle were initially processed as a group during the following time periods?
None

Some

Most

All

DK

a. 24 hours or less after arrival

1

2

3

4

5

b. 25 to 72 hours after arrival

1

2

3

4

5

c. 73 hours to 2 weeks after arrival
d. 2 to 4 weeks after arrival
e. Not processed as a group at placement

1
1
1

2
2
2

3
3
3

4
4

5
5
5

11. When cattle were initially processed as a group at placement, what proportion of the cattle had the
following procedures performed? Answer 1 for “None” or 0% of cattle, 2 for “Some” for 50% or less, 3 for
“Most” or 51% or more, 4 for “All” or 100%, or DK for “Don’t Know.” Answer for all cattle of all weight classes
at arrival. If the answer is 2 or 3, “Some” or “Most,” then also answer by arrival weight class if possible.
[Refer to Reference Card 2 (Vaccine Examples) for examples of common trade names of vaccines. For
combination products, enter information into all relevant rows]
Weights at arrival
All
Cattle

Vaccinations

Cattle
<400 lb

Cattle
400-699 lb

Cattle
≥700 lb

a. Vaccination against bovine viral diarrhea (BVD)?
b. Vaccination against clostridial diseases (e.g., blackleg)?
c. Vaccination against tetanus specifically?
d. Vaccination against Moraxella (pinkeye)?
e. Vaccination against any respiratory diseases?
[If Question 11e = 0% for all, SKIP to Other Procedures 11i]
f. Injectable vaccination against viral respiratory disease?
g. Intranasal vaccination against viral respiratory disease?
h. Vaccination against bacterial respiratory disease due to
Mannheimia and/or Pasteurella?
Other procedures
i. Testing for bovine viral diarrhea (BVD) infection
j. Implantation?
k. Administration of a parasiticide?
l. Administration of an immunostimulant (e.g., Zelnate™)?
m. Individual weighing of the animal?
n. Taking the temperature of the animal?
o. Listening to lungs with stethoscope?
p. Administration of injectable antibiotic?
q. Administration of vitamin and/or mineral injection?
r. Other procedure? (specify:_______________________)
VS Form 21-303
September 2020

4

NAHMS ID: _____________________

12. Continue to enter 1 for None, 2 for Some, 3 for Most, 4 for All, and DK for Don’t Know
for these questions about subgroups of cattle.
Heifers

a. For heifers, what proportion had a pregnancy check at arrival?
b. For heifers, what proportion were administered an abortifacient such as
prostaglandin at arrival?
c.

Bulls or bull
calves

For bulls and bull calves, what proportion arrived at the feedlot uncastrated?
Non-polled cattle

d. For non-polled cattle, what proportion arrived at the feedlot with horns?
[If Question 12d = None or DK, SKIP to Question 13]
e. What proportion of non-polled cattle were dehorned at the feedlot?
f.

What proportion of non-polled cattle were tipped at the feedlot?

13. How frequently did you conduct pen-riding or walking procedures for:
[Enter one code for each line: 1. Once a day; 2. Twice a day; 3. More than twice a day; 4. Less than
once a day; 5. No standard procedure]
a. New arrivals (at feedlot less than 15 days)?
b. Animals at feedlot 15 to 30 days?
c. Animals at feedlot 30 days or more?
14. Were the following used to mitigate weather-related stress on this feedlot?
a.
b.
c.
d.

Shade/shelter
Sprinklers, misters, and/or water trucks
Wind breaks
Building mounds

1 Yes 3 No 4 DK
1 Yes 3 No 4 DK
1 Yes 3 No 4 DK
1 Yes 3 No 4 DK

e. Feed additives, such as yeast, essential oils, or pepper extract
f.

Other (specify: ____________________________________________)

1 Yes 3 No 4 DK
1 Yes

Disease Conditions
15. What percentage of all placed cattle of the following arrival weight classes were affected with bovine
respiratory disease (BRD) from September 1, 2019 to August 31, 2020? What percentage of all placed
cattle of the following arrival weight classes died due to bovine respiratory disease during this time period?
[If it is not possible to estimate these percentages stratified by weight classes, enter DK for Don’t Know and
complete the cattle of all arrival weight classes row. If it is not possible to estimate the percentage for all
arrival weight classes, enter DK for Don’t Know ]
Affected
%

a. Cattle less than 400 lb at arrival

Died

%

b. Cattle 400 to 699 lb at arrival

%

%

c.

%

%

%

%

Cattle 700 lb or greater at arrival
OR

d. Cattle of all arrival weight classes
[If Question 15 all = 0 or DK, SKIP to Question 19]
VS Form 21-303
September 2020

5

NAHMS ID: _____________________

16. The occurrence of BRD on feedlots can vary throughout the year for many reasons,
particularly seasonal factors. What percentage of cattle were affected with BRD on this
feedlot during the fall/winter months compared to the spring/summer months? If this is
unknown, enter “DK” for Don’t Know.
a. Cattle affected with BRD in fall/winter months
b. Cattle affected with BRD in spring/summer months
c. Total (Cattle affected with BRD all year)
17. How did the overall percentage of cattle on this feedlot affected with BRD
seasonally compare to the expected or “normal” percentages on this feedlot for:
[Check one only]

Percentage of
cattle affected with
BRD

100%

Lower

Similar

Higher

a. BRD in fall/winter months

1

2

3

b. BRD in spring/summer months

1

2

3

[If Question 17.a and 17.b = Similar, SKIP to Question 19]
18. If the percentage of cattle affected with BRD was higher or lower than expected, describe reasons why
you think this occurred in the space at the end of the questionnaire.
19. What percentage of cattle developed the following conditions from September 1, 2019 to August 31,
2020? If you are not familiar with the condition or do not think you can provide an accurate estimate of the
percentage of cattle that developed it, answer DK.
[Refer to Reference Card 3 (Disease Conditions) for descriptions of these disease conditions]
% 4 DK
a. Acute interstitial pneumonia (i.e., AIP, dust pneumonia, atypical pneumonia)
b. Bloat

% 4 DK

c.

% 4 DK

Other digestive disorders excluding bloat (e.g., coccidiosis, diarrhea)

d. Footrot (infectious pododermatitis)

% 4 DK

e. Hairy heel wart (papillomatous digital dermatitis)

% 4 DK

f.

% 4 DK

Central nervous system (CNS) disease (e.g., polio, listeriosis, “brainers”)

g. Pinkeye

% 4 DK

h. Cardiovascular disease (e.g., heart failure, brisket disease)

% 4 DK

i.

Fatigued cattle syndrome

% 4 DK

j.

Other (specify:________________________________________________)

%

[If Question 19.e. Hairy heel wart = 0% or DK, skip to Question 22]
20. Were the following used for therapy of hairy heel wart?
a. Cattle footbaths
b. Topical sprays
[If both 20.a and 20.b = No, SKIP to Question 22]

1 Yes 3 No
1 Yes 3 No

21. What was the active ingredient in the footbaths or sprays? [Check one only]
1
2
3
4

Copper sulfate
Formalin/formaldehyde
Hydrogen peroxide
Oxytetracycline

5 Other (specify: ____________________________________________________________________)
VS Form 21-303
September 2020

6

NAHMS ID: _____________________

22. When cattle died on this feedlot, what proportion of cattle had a
post-mortem examination (i.e., necropsy) performed?

None

Some

Most

All

DK

1

2

3

4

5

23. Are the following given to sick cattle as part of the initial course of treatment for:
Bovine
respiratory
disease

Digestive
disorders other
than bloat
(e.g., coccidiosis,
diarrhea)

Footrot

Pinkeye

 No BRD

 No digestive
disorders

 No footrot

 No pinkeye

a. Injectable antibiotic?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

b. Bolus-dosed oral antibiotic?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

c. In feed antibiotic?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK
1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

Treatment

If no disease, SKIP column

d. Topical antibiotic?
e. Respiratory vaccine?

1 Yes 3 No
4 DK

f. Corticosteroid (e.g., Azium®)?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

g. Nonsteroidal anti-inflammatory (e.g.,
Banamine®, aspirin)?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

h. Antihistamine?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

i. Vitamin B injection?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

j. Vitamin C injection?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

k. Immunostimulant (e.g., Zelnate™)?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

l. Injectable mineral supplement (e.g.,
MultiMin®)?

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

m. Probiotic paste

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

n. Other?
(specify:________________________)

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

1 Yes 3 No
4 DK

VS Form 21-303
September 2020

7

NAHMS ID: _____________________

24. Were there separate pens to house sick cattle (e.g., hospital pens)?

1 Yes 3 No 4 DK

[If question 24 = No or DK, SKIP to Question 26]
25. Were the following resources provided to cattle in the hospital pen? Answer none of the time, some of
the time (as needed), or all of the time.
None of
the time

Some
of the
time

All of the
time

DK

a. Wind breaks

1

2

3

4

b. Shade

1

2

3

4

c. Sprinklers/misters to keep cattle cool

1

2

3

4

d. Additional bedding (e.g., straw) compared to home pen

1

2

3

4

e. Additional hay to eat compared to home pen

1

2

3

4

f. Increased waterer/bunk space per animal compared to home pen

1

2

3

4

g. Increased observation/surveillance compared to home pen

1

2

3

4

h. Dust control

1

2

3

4

i. Other (specify: _____________________________________)

1

2

3

4

26. Did you receive information from slaughter facilities about the percentage of cattle
from this feedlot affected with liver abscesses resulting in condemnation of livers?

1 Yes 3 No
4 DK

[If Question 26 = No or DK, SKIP to Question 28]
27. Approximately what percentage of slaughtered cattle of the following types had liver condemnations
due to liver abscesses?
a. Beef breed cattle given in-feed

antibiotics
b. Dairy or dairy cross breed cattle
given in-feed antibiotics
c. Beef breed cattle NOT given in-feed
antibiotics
d. Dairy or dairy cross breed cattle
NOT given in-feed antibiotics

Placed on this
feedlot?

1 Yes
3 No
1 Yes
3 No
1 Yes
3 No
1 Yes
3 No

Percentage with liver
condemnations?

If No, SKIP to 27b
If Yes 

%

4 DK

If No, SKIP to 27c
If Yes 

%

4 DK

If No, SKIP to 27d
If Yes 

%

4 DK

If No, SKIP to 28
If Yes 

%

4 DK

28. Over the past 5 years, has there been an increase in death loss in latefed cattle on this feedlot (i.e., cattle fed 100 days or more)?

1 Yes 3 No 4 DK

[If Question 28 = No or DK, SKIP to Section B]
29. Were the following associated with this increased late-fed death loss?
a. Bovine respiratory disease, excluding acute interstitial pneumonia
b. Acute interstitial pneumonia (i.e., dust pneumonia, atypical pneumonia)
c. Injury
d. Fatigued cattle syndrome
e. Heart failure
f. Other (specify: ____________________________________)

VS Form 21-303
September 2020

1 Yes 3 No 4 DK
1 Yes 3 No 4 DK
1 Yes 3 No 4 DK
1 Yes 3 No 4 DK
1 Yes 3 No 4 DK
1 Yes

8

NAHMS ID: _____________________

Section B—Antibiotic Use
1. Were any antibiotics used in cattle on this feedlot (all forms; e.g., injectable,
bolus-dosed, in feed, and/or in water) from September 1, 2019 to August 31,
2020?

1 Yes 3 No 4 DK

[If Question 1 = No or DK, SKIP to Section C]
Injectable and Bolus-Dosed Antibiotic Use
1 Yes 3 No 4 DK

2. Were injectable or bolus-dosed antibiotics used on this feedlot?
[If Question 2 = No or DK, SKIP to Question 12]

3. How important are the following factors in the selection of injectable and bolus-dosed antibiotics?
Not
Important

Slightly
Important

Moderately
Important

Very
Important

Extremely
Important

a. Veterinarian recommendations

1

2

3

4

5

b. Other producers’ recommendations

1

2

3

4

5

c.

1

2

3

4

5

d. Drug company advertisement

1

2

3

4

5

e. Personal experience (past response rates)

1

2

3

4

5

f.

1

2

3

4

5

g. Approved route by which antibiotic is given

1

2

3

4

5

h. Duration of action (e.g., only needs to be
given once)
i. Drug withdrawal time

1

2

3

4

5

1

2

3

4

5

j.

Over the counter availability

1

2

3

4

5

k.

Other (specify ______________________)

1

2

3

4

5

Laboratory test results

Cost of antibiotic

4. For this question, individual treatment is defined as the administration of
antibiotics only to those cattle identified to be sick.
Were cattle administered injectable or bolus-dosed antibiotics for the
individual treatment of bovine respiratory disease (BRD)?

1 Yes 3 No 4 DK

[If Question 4 = No or DK, SKIP to Question 8]

VS Form 21-303
September 2020

9

NAHMS ID: _____________________
5. For this question, consider only the cattle that you identified in Section A, Question 15; Page 5, to be
affected with BRD. For each of the following injectable or bolus-dosed antibiotics, what percentage
of these cattle were individually treated for BRD with this antibiotic for their initial treatment?
[Answer by weight class at arrival if possible. Otherwise, answer by % all sick cattle Write in DK if the
estimate is unknown. Refer to Reference Card 4 (Antibiotics Given via Injection or Bolus)]
Active ingredient name (Trade name examples) % sick cattle
<400 lb

Arrival Weight
% sick cattle
400 - 699 lb

% all
sick
cattle

% sick cattle
≥700 lb

a. Tilmicosin (Micotil®)
b. Gamithromycin (Zactran®)
c. Tulathromycin (Draxxin®)
d. Tylosin (Tylan® 200)
e. Tildipirosin (Zuprevo®)
f. Florfenicol (Nuflor®)
g. Florfenicol w/ flunixin meglumine (Resflor Gold®)
h. Enrofloxacin (Baytril®)
i. Danofloxacin (Advocin™)
j. Ceftiofur (Naxcel®, Excenel®, Excede®)
k. Oxytetracycline (LA-200®, Oxytet 100, BioMycin®)
l. Penicillin (Aquacillin™, Penicillin G Procaine)
m. Ampicillin (Polyflex®)
n. Sulfadimethoxine (Albon® Injection)
o. Sulfadimethoxine (Albon® Bolus)
p. Sulfamethazine (Sustain III® Bolus, Supra Sulfa® III)

OR

6. Of the sick cattle described in Question B5 that were initially treated for BRD, what percentage:
[Answer by weight class at arrival if Question B5 was answered by weight class. If Question
B5 was answered for all cattle, answer by % all sick cattle. Write DK if unknown]
Arrival Weight
% sick cattle
<400 lb

% sick cattle
400-699 lb

% all sick
cattle

% sick
cattle ≥700
lb

a. Responded and recovered?

%

OR

b. Died or were euthanized?

%

c. Were considered chronics and marketed early?

%

d. Did not respond and were re-treated?

%

7. For this question, GROUP administration of antibiotics means that the majority
of the pen was given an antibiotic at one time.
Were cattle on your feedlot administered injectable or bolus-dosed antibiotics
as a GROUP for the prevention, control, or treatment of BRD?

1 Yes 3 No 4 DK

[If Question 7= No or DK, SKIP to Question 9]

VS Form 21-303
September 2020

10

NAHMS ID: _____________________
8. For each of the following injectable or bolus-dosed antibiotics, what percentage of cattle were given this
antibiotic as a GROUP for the prevention, control, or treatment of BRD?
[Answer by weight class at arrival if possible. If not, answer for all cattle overall. Write in DK if the estimate
is unknown. Refer to Reference Card 4 (Antibiotics Given via Injection or Bolus)]
Arrival Weight

Active ingredient name (Trade name examples)
a. Tilmicosin (Micotil®)
b. Gamithromycin (Zactran®)
c. Tulathromycin (Draxxin®)
d. Tylosin (Tylan® 200)
e. Tildipirosin (Zuprevo®)
f. Florfenicol (Nuflor®)
g. Florfenicol w/ flunixin meglumine (Resflor Gold®)
h. Enrofloxacin (Baytril®)
i. Danofloxacin (Advocin™)
j. Ceftiofur (Naxcel®, Excenel®, Excede®)
k. Oxytetracycline (LA-200®, Oxytet 100, BioMycin®)
l. Penicillin (Aquacillin™, Penicillin G Procaine)
m. Ampicillin (Polyflex®)
n. Sulfadimethoxine (Albon® Injection)
o. Sulfadimethoxine (Albon® Bolus)
p. Sulfamethazine (Sustain III® Bolus, Supra Sulfa® III)

% cattle
<400 lb

% cattle 400 699 lb

% all
cattle

% cattle
≥700 lb

OR

9. Were sick cattle on your feedlot administered injectable or bolus-dosed
antibiotics for the individual treatment of conditions other than BRD?

1 Yes 3 No 4 DK

[If Question 9 = No or DK, SKIP to Question 11]
10. For this question, consider only the cattle that you identified in Section A, Question 19; Page 6 to
have developed the conditions in that question, also listed in the reason codes below. If an injectable or
bolus-dosed antibiotic in the list below was used to individually treat cattle with these conditions, enter
the reason code corresponding to the most common reason (primary reason) in the list that this
antibiotic was used. [Refer to Reference Card 4 (Antibiotics Given via Injection or Bolus)]
Active ingredient name
(Trade name examples)

a. Tilmicosin (Micotil®)
b. Gamithromycin (Zactran®)
c. Tulathromycin (Draxxin®)
d. Tylosin (Tylan® 200)
e. Tildipirosin (Zuprevo®)
f. Florfenicol (Nuflor®)
g. Florfenicol with flunixin meglumine (Resflor Gold®)
h. Ceftiofur (Naxcel®, Excenel®, Excede®)
i. Oxytetracycline (LA-200®, Oxytet 100, BioMycin®)
j. Penicillin (Aquacillin™, Penicillin G Procaine)
k. Ampicillin (Polyflex®)
l. Sulfadimethoxine (Albon® Injection)
m. Sulfadimethoxine (Albon® Bolus)
n. Sulfamethazine (Sustain III® Bolus, Supra Sulfa® III)

VS Form 21-303
September 2020

Reason
Code

Reason Codes for Question 10

1

Acute Interstitial Pneumonia

2
3
4
5
6
7
8
9

Bloat
Other digestive disorders
Footrot
Hairy heel wart
CNS disease
Pinkeye
Cardiovascular disease
Fatigued cattle syndrome
Other
(specify:__________________)

10

11

NAHMS ID: _____________________
Antibiotic Use in Feed
11. Were any antibiotics used in feed on this feedlot?
Include antibiotics that DO require a veterinary feed directive such as
chlortetracycline and tylosin, and antibiotics that DO NOT require a veterinary feed
directive (VFD), such as ionophores (e.g., Rumensin®, Monovet®, Bovatec®, and
Cattlyst®), bambermycin, and bacitracin.

1 Yes 3 No 4 DK

If Question 11 = No or DK, SKIP to Question 16]
12. For each of the following antibiotics that DO NOT require a VFD, what percentage of cattle overall
received it in feed for any reason? If the antibiotic was used, designate up to 2 reason codes from the box
below and the percentage of cattle that received it specifically for the reason(s).
[Refer to Reference Card 5 (Antibiotics Given via Feed or Water)]
Reason codes for Question 12
1
Coccidiosis
2
Growth promotion/improved feed efficiency
3
Reduction in the number of liver condemnations due to abscesses
4
Other (specify:_________________________________________________________)
Active ingredient name
(Trade name examples)

% cattle
overall

Reason
Code I

a. Any ionophore (e.g., Rumensin®, Bovatec®)
b. Bambermycin (Gainpro® 10)
c. Bacitracin (BMD®, Baciferm®)

% cattle
for Reason
Code I

Reason
Code II

% cattle
for Reason
Code II

13. This question asks about in-feed antibiotics that DO require a VFD used in cattle that were less than
700 lb at arrival. For each of the following antibiotics, what percentage of cattle less than 700 lb at arrival
overall received it in feed for any reason? If the antibiotic was used, designate up to 2 reason codes from
the box below and the percentage of cattle that received it specifically for the reason(s).
[Refer to Reference Card 5 (Antibiotics Given via Feed or Water)]
Reason codes for Question 13
1
Liver abscesses
2
Respiratory disease (e.g., bacterial pneumonia, shipping fever)
3
Gastrointestinal disease (e.g., bacterial enteritis [diarrhea])
4
Anaplasmosis
5
Other (specify:_________________________________________________________)
Active ingredient name
(Trade name examples)
a. Chlortetracycline (Aureomycin®, Aureomix®, CTC)
b. Oxytetracycline (Terramycin®, OTC)
c. Sulfamethazine/sulfadimethoxine (Aureomix®)
d. Neomycin (Neomix)
e. Tylosin (Tylan, Tylovet)
f. Virginiamycin (Vmax)
g. Tilmicosin (Pulmotil®, Tilmovet®)

VS Form 21-303
September 2020

% cattle
overall

Reason
Code I

% cattle
for Reason
Code I

Reason
Code II

% cattle
for Reason
Code II

12

NAHMS ID: _____________________
14. This question asks about in-feed antibiotics that DO require a VFD used in cattle that were 700 lb or
greater at arrival. For each of the following antibiotics, what percentage of cattle 700 lb or greater at
arrival overall received it in feed for any reason? If the antibiotic was used, designate up to 2 reason
codes from the box below and the percentage of cattle that received it specifically for the reason(s).
[Refer to Reference Card 5 (Antibiotics Given via Feed or Water)]
Reason codes for Question 14
1
Liver abscesses
2
Respiratory disease (e.g., bacterial pneumonia, shipping fever)
3
Gastrointestinal disease (e.g., bacterial enteritis [diarrhea])
4
Anaplasmosis
5
Other (specify:_________________________________________________________)
Active ingredient name
(Trade name examples)
a. Chlortetracycline (Aureomycin®, Aureomix®, CTC)
b. Oxytetracycline (Terramycin®, OTC)
c. Sulfamethazine/sulfadimethoxine (Aureomix®)
d. Neomycin (Neomix)
e. Tylosin (Tylan, Tylovet)
f. Virginiamycin (Vmax)
g. Tilmicosin (Pulmotil®, Tilmovet®)

%
cattle
overall

Reason
Code I

% cattle
for Reason
Code I

Reason
Code II

% cattle
for Reason
Code II

[If Question B13.a and B14.a = 0, i.e. no chlortetracycyline was used in feed, SKIP to Question 16.
If chlortetracycline was used but reason code was NOT 2, SKIP to Question 16]
15. In-feed chlortetracycline (10 mg/lb/day) is currently approved for use in cattle for 5 days to treat
respiratory disease. If cattle do not respond to this pulse treatment, producers have the option to obtain a
second VFD from a veterinarian to administer a second pulse, and so on.
When chlortetracycline was used in feed for the treatment
of respiratory disease, what proportion of pen groups
treated with chlortetracycline required more than one pulse
treatment?

None

Some

Most

All

DK

0

1

2

3

4

Answer None (0%), Some (50% or less), Most (more than 50%), or
All (100%).

Antibiotic Use in Water
16. Were any antibiotics used in water on this feedlot?

1 Yes 3 No 4 DK

[If Question 16 = No or DK, SKIP to Section C]

VS Form 21-303
September 2020

13

NAHMS ID: _____________________
17. For each of the following in-water antibiotics, what percentage of cattle overall received it in water for
any reason? If the antibiotic was used, designate up to 2 reason codes from the box below and the
percentage of cattle that received it specifically for the reason(s).
[Refer to Reference Card 5 (Antibiotics Given via Feed or Water)]
Reason codes for Question 16
1
Respiratory disease (e.g., bacterial pneumonia, shipping fever)
2
Gastrointestinal disease (e.g., bacterial enteritis [diarrhea])
3
Pinkeye
4
Footrot
5
Other (specify:_________________________________________________________)
Active ingredient name

% cattle
overall

Reason
Code I

% cattle
for Reason
Code I

Reason
Code II

% cattle
for Reason
Code II

a. Chlortetracycline (Aureomycin®, Aureomix®, CTC)
b. Oxytetracycline (Terramycin®, OTC)
c. Tetracycline (Duramycin, Tet-Sol)
d. Sulfamethazine/sulfadimethoxine (Sulfasol)
e. Neomycin (Neosol)
f. Spectinomycin (Spectam, SpectoGard)

VS Form 21-303
September 2020

14

NAHMS ID: _____________________

Section C—Nutrition
1. Of all cattle placed on feed, what percentage were ever given the following during the feeding period?
a. A coccidiostat other than an ionophore, such as amprolium (e.g., Corid®) or
% 4 DK
decoquinate (e.g., Deccox®)?
b. A beta-agonist (e.g., ractopamine)
% 4 DK
1 Yes 3 No 4 DK

2. Did this feedlot use the services of a nutritionist?

3. Which of the following water sources were used for the cattle on this feedlot?
a. Ground water (well)
1 Yes 3 No 4 DK
b. Surface water (ponds, lakes, streams, water storage from river flows)
1 Yes 3 No 4 DK
c.

Municipal water supply

1 Yes 3 No 4 DK

4. Were any of the following feed additives used on this feedlot? If yes, which of the following were
reasons they were included in the ration? [Check all that apply]
If used on feedlot, for what reason(s)
Used on
feedlot?

Improve
growth
rate and/or
feed
efficiency

Antibiotic
Alternative

Bovine
respiratory
disease

Hoof
health

Preharvest
food
safety

Reduce
liver
abscesses

a. Direct-fed microbial or
probiotic (e.g.,
Lactobacillus acidophilus
or yeast)

1 Yes
3 No

1

2

3

4

5

6

b. Yeast fermentation
products

1 Yes
3 No

1

2

3

4

5

6

c. Prebiotics (e.g., mannanoligosaccharides)

1 Yes
3 No

1

2

3

4

5

6

d. Vitamin supplements

1 Yes
3 No

1

2

3

4

5

6

e. Organic mineral
supplements

1 Yes
3 No

1

2

3

4

5

6

f. Inorganic mineral
supplements

1 Yes
3 No

1

2

3

4

5

6

g. Enzymes

1 Yes
3 No

1

2

3

4

5

6

h. Essential oils and plantderived products (e.g.,
yucca extract)

1 Yes
3 No

1

2

3

4

5

6

i. Other
(specify:_____________)

1 Yes
3 No

1

2

3

4

5

6

VS Form 21-303
September 2020

15

NAHMS ID: _____________________

Section D—Biosecurity
1.
a.
b.
c.
d.
e.
f.
g.
h.
i.
j.

Were the following practices used on this feedot?
Control access for visitors entering animal areas
Disposable or clean boots for visitors entering animal areas
Footbaths for visitors entering animal areas
Restrictions on vehicles entering animal area
Restrict movement of horses onto the feedlot premises
Insect control
Rodent control
Bird control
Have dead cattle picked up at edge of property
Compost deads on site

1 Yes 3 No 4 No visitors
1 Yes 3 No 4 No visitors
1 Yes 3 No 4 No visitors
1 Yes 3 No 4 No vehicles
1 Yes 3 No 4 No horses
1 Yes 3 No
1 Yes 3 No
1 Yes 3 No
1 Yes 3 No
1 Yes 3 No

2. Did this feedlot have a written or electronic biosecurity plan?

1 Yes 3 No 4 DK

3. Does this feedlot have a shared fenceline with another operation
such that there could be nose to nose contact with other cattle,
bison or other ruminants?

1 Yes 3 No 4 DK

[If Question 3 = YES, then SKIP to Question 5]
4. How close, to the nearest ½ mile, is this feedlot to another operation with
cattle, bison, or other ruminants?

miles

5. How many employees directly involved in cattle care did this feedlot have on average
from September 1, 2019 to August 31, 2020?

Number of
employees

[If Question 5 = 0, SKIP to Question 7]
6. Did employees of this feedlot…
a. Have contact with cattle, bison, or other ruminants on other operations?

1 Yes 3 No 4 DK

b. Own cattle, bison, or other ruminants at another location?

1 Yes 3 No 4 DK

7. Did cattle stay in the same pen during the entire feeding period?

1 Yes 3 No 4 DK

[If Question 7 = YES or DK, then SKIP to Question 9]
Number

8. How many times were cattle re-sorted during the feeding period?
9. How familiar are you with the Secure Beef Supply Plan? [Check one only]
1 Very familiar
2 Somewhat familiar
3 Heard of name only
4 Not familiar

VS Form 21-303
September 2020

16

NAHMS ID: _____________________

Thank you for your help in completing this survey. Please feel free to use the following space and
the back of this questionnaire to communicate comments about the survey or any other
information about health management on your feedlot that you think is relevant.

VS Form 21-303
September 2020

17

NAHMS ID: _____________________

Section E—Office Use Only
State FIPS:__________
2-digits

Operation #:_________
5-digits

Interviewer:___________ Date:
/
/
Initials
(mm/dd/yy)

1. Total time for interview [include time to discuss the program
and complete the questionnaire] ...............................................................................

_____ min

2. Total travel time [round trip] ......................................................................................

_____ min

3. Data collector(s) (Enter the number for each category.)
_____ Federal VMO

_____ Other (specify in margin)

VFED/VOTH

_____ State VMO

VST

4. Enter response code 99 if questionnaire is completed or enter
one code of 00 through 07 that best describes the reason why the owner
is not participating .....................................................................................................

_____ code

99 = Survey completed
00 = Producer not contacted by VMO
01 = Poor time of year to contact or no time available to participate
02 = Doesn’t want anyone on operation
03 = Bad experience with government veterinarian(s)
04 = Doesn’t want to do another survey or divulge information
05 = Told NASS they didn’t want to be contacted by VS
06 = Ineligible (no longer in operation)
07 = Other (explain in the comments section below)
5. Which of the following best describes the respondent’s position
with this operation? ............................................................................................

_____ code

1 = Owner
2 = Manager
3 = Family member (other than owner or manager)
4 = Other hired employee (non-veterinarian)
5= Veterinarian on staff (e.g., company veterinarian)
6= Herd veterinarian or other veterinarian
7 = Other (specify: _______________________________)
6. Producer data quality ..................................................

1 Good to excellent

2 OK

3 Poor

7. Comments regarding this questionnaire or operation:
VMO signature: ___________________________________________________
TO BE COMPLETED BY COORDINATOR:
8. Field data quality…………………………………………………1 Good to excellent

VS Form 21-303
September 2020

2 OK

3 Poor

18

NAHMS ID: _____________________

REFERENCE CARD 1: Paperwork Reduction Act
According to the Paperwork Reduction Act of 1995, an agency may not conduct or sponsor, and a
person is not required to respond to a collection of information unless it displays a valid OMB control
number. The valid OMB control number for this information collection is 0579-0079. The time required
to complete this information collection is estimated to average 1 hour per response, including the time
to review instructions, search existing data resources, gather the data needed, and complete and
review the information collected.
UNITED STATES DEPARTMENT OF AGRICULTURE
ANIMAL AND PLANT HEALTH INSPECTION SERVICE
VETERINARY SERVICES
NATIONAL ANIMAL HEALTH MONITORING SYSTEM
2150 CENTRE AVE, BLDG B
FORT COLLINS, CO 80526

OMB Approved
0579-0079
EXP: XX/20XX

Health Management on
U.S. Feedlots 2020
Phase 2 Questionnaire

VS Form 21-303
September 2020

19

NAHMS ID: _____________________

REFERENCE CARD 2: Vaccine Examples

[For use with Phase 2 questionnaire, Section A, Question 11]
Type of Vaccine

Example trade names

Boehringer Ingelheim Elite, Express, Prism, Pyramid, Triangle
Colorado Serum Pre-Breed, Respira
Injectable vaccines against
Elanco Master Guard, Titanium, Vira Shield
BVD and/or viral respiratory
Merck Vista
disease (e.g., IBR, BVD,
Texas Vet Lab Multi-Vac 3L, Super Poly-Bac B
PI3, BRSV)
Zoetis Bovi-Shield 4, GOLD, and IBR, Cattle Master, One Shot
BVD or Ultra 7, PregGuard GOLD FP 10, Resvac 4/Somubac
Intranasal vaccines against
BVD and/or viral respiratory Zoetis Inforce 3, TSV-2
disease (e.g., IBR, BVD,
Merck Nasalgen IP
PI3, BRSV)

Vaccines against bacterial
respiratory disease
(Mannheima haemolytica
and Pasteurella multocida)

Vaccines against clostridial
diseases

Vaccines against Moraxella
(pinkeye)

VS Form 21-303
September 2020

AgriLabs Pulmo-Guard
Boehringer Ingelheim Bar Somnus 2P, Presponse, Triangle 4 or 9 PH-K,
Pyramid+Presponse, Bo-Bac 2X
Colorado Serum Mannheimia Haemolytica-Pasteurella Multocida
Bacterin
Elanco Titanium PH-M, Nuplura PH, Vira Shield 6 +/- Somnus
Durvet Durvac Past HM
Immvac ENDOVAC
Merck Vista Once SQ, Once PMH
Texas Vet Lab Poly-Bac B or Super Poly-Bac B
Zoetis Bovi-Shield GOLD One Shot, One Shot, One Shot Ultra
Boehringer Ingelheim Alpha 7 or CD, Bar-Vac,, Caliber 3 or 7
Colorado Serum Essential
Elanco Pili Shield + C, Clostri Shield, Scour Bos 9
Merck 20/20 Vision 7 with Spur, Cavalry 9, Covexin 8, Guardian,
Vision 7, 8, CD, or DC-T with Spur, Piliguard Pinkeye + 7,
Super-Tet with Havlogen
Professional Biological Clostridium perfringens Type C&D Toxoid
and Toxoid-Tetanus Toxoid
Zoetis One Shot Ultra 7 or 8, Ultrabac 7, 8, or CD, UltraChoice 7,
8, or CD, ScourGuard 4KC
AgriLabs I-Site XP, Moraxella bovoculi bacterin
Addison Maxi/Guard Pinkeye Bacterin
Boehringer Ingelheim Ocu-Guard-MB-1, Alpha7/MB-1
Elanco Pinkeye Shield XT4
Merck 20/20 Vision 7 with Spur, Piliguard Pinkeye+7, Piliguard Pinkeye-1
Trivalent
Zoetis SolidBac Pinkeye IR/PR

20

NAHMS ID: _____________________

REFERENCE CARD 3: Disease Conditions other than BRD
Code Disease Condition

VS Form 21-303
September 2020

1

Acute Interstitial Pneumonia (e.g.,
AIP, dust pneumonia, atypical
pneumonia

2

Bloat

3

Other digestive disorders (e.g.,
coccidiosis, diarrhea)

4

Footrot

5

Hairy heel wart

6

Central Nervous System disease
(e.g., polio, listeriosis, “brainers”)

7

Pinkeye

8

Cardiovascular disease (e.g., heart
failure, brisket disease)

9

Fatigued cattle syndrome

10

Other

21

NAHMS ID: _____________________

REFERENCE CARD 4: Antibiotics Given via Injection or Bolus
Codes are provided for use in electronic questionnaire and are not necessary for paperadministered questionnaire
ANTIBIOTICS GIVEN VIA INJECTION OR BOLUS
Code Active Ingredient

Product Name

1

Tilmicosin

Micotil

2

Gamithromycin

Zactran

3

Tulathromycin

Draxxin

4

Tylosin

Tylan 200

5

Tildipirosin

Zuprevo

6

Florfenicol

Nuflor

7

Florfenicol with Flunixin meglumine

Resflor Gold

8

Enrofloxacin*

Baytril

9

Danofloxacin*

Advocin

10

Ceftiofur

Naxcel, Excenel, Excede

11

Oxytetracycline

LA-200, Oxytet 100, BioMycin

12

Penicillin

Aquacillin, Penicillin G Procaine

13

Ampicillin

Polyflex

14

Sulfadimethoxine (injectable)

Albon Injection

15

Sulfadimethoxine (Bolus)

Albon Bolus

16

Sulfamethazine

Sustain III Bolus, Supra Sulfa

*These antibiotics are labeled only for the treatment of bovine respiratory disease (BRD) associated with
Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and nonlactating dairy cattle and for the control of BRD in beef and non-lactating dairy cattle at high risk of
developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and
Mycoplasma bovis, and their extra-label use is prohibited. Therefore, these antibiotics are not presented
as options for Section B, Question 10 (individual treatment of conditions other than BRD).

VS Form 21-303
September 2020

22

NAHMS ID: _____________________

REFERENCE CARD 5: Antibiotics Given via Feed or Water
Codes for antibiotics that don’t require a veterinary feed directive (VFD) are not necessary for
either the electronic questionnaire or the paper-administered questionnaire so are not provided
ANTIBIOTICS USED IN FEED THAT DO NOT REQUIRE A VFD
Active Ingredient

Product Name

Ionophore

Rumensin, Bovatec

Bambermycin

Gainpro 10

Bacitracin

BMD, Baciferm

Codes for VFD antibiotics and antibiotics used in water are provided for use in electronic
questionnaire and are not necessary for paper-administered questionnaire
ANTIBIOTICS USED IN FEED THAT DO REQUIRE A VFD
Code Active Ingredient

Product Name
Aureomycin,
Aureomix
Terramycin, OTC

1

Chlortetracyline

2

4

Oxytetracycline
Sulfamethazine /
Sulfadimethoxine
Neomycin

5

Tylosin

Tylan, Tylovet

6

Virginiamycin

Vmax

7

Tilmicosin

Pulmotil, Tilmovet

3

Aureomix
Neomix

ANTIBIOTICS USED IN WATER
Code Active Ingredient
1

Chlortetracyline

2

Oxytetracycline

3

5

Tetracycline
Sulfamethazine /
Sulfadimethoxine
Neomycin

6

Spectinomycin

4

VS Form 21-303
September 2020

Product Name
Aureomycin,
Chloronex
Terramycin, OTC
Duramycin, Tet-Sol
Sulfasol
Neosol
Spectam,
SpectoGard

23


File Typeapplication/pdf
AuthorLombard, Jason E - APHIS
File Modified2020-01-17
File Created2020-01-17

© 2024 OMB.report | Privacy Policy